Volitionrx (VNRX) Net Cash Flow (2011 - 2025)

Volitionrx's Net Cash Flow history runs 15 years deep, the most recent figure standing at $652971.0 for Q4 2025.

• Quarterly Net Cash Flow rose 119.55% year-over-year to $652971.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$2.7 million (up 84.95% YoY) and the FY2025 annual result came in at -$2.7 million, up 84.95% from the prior year.
• Net Cash Flow was $652971.0 for Q4 2025 at Volitionrx, up from -$2.0 million in the prior quarter.
• Across five years, Net Cash Flow topped out at $13.6 million in Q1 2021 and bottomed at -$9.0 million in Q3 2023.
• A 5-year average of -$976706.8 and a median of -$1.4 million in 2023 frame the typical range for Net Cash Flow.
• Peak annual rise in Net Cash Flow reached 354.31% in 2021, while the deepest fall reached 4367.05% in 2021.
• Volitionrx's Net Cash Flow stood at -$2.4 million in 2021, then slumped by 123.58% to -$5.5 million in 2022, then surged by 281.61% to $9.9 million in 2023, then sank by 133.7% to -$3.3 million in 2024, then soared by 119.55% to $652971.0 in 2025.
• Business Quant data shows VNRX's Net Cash Flow at $652971.0 in Q4 2025, -$2.0 million in Q3 2025, and -$669448.0 in Q2 2025.